Neuroscience Research on Drug Abuse (R21)
National Institutes of Health · Opportunity PA-07-227
Multiple Receipt Dates - See Link to Full Announcement for details.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
About this opportunity
-Purpose. The National Institute on Drug Abuse (NIDA) requests research grant applications in the areas of neuroscience and behavioral neuroscience research that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R21) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-226, that solicits applications under the R01 mechanism and PA-07-228 that solicits applications under the R03 mechanism. Applications of related or identical scientific scope are solicited also under the Academic Research Enhancement Award (R15) (http://grants.nih.gov/grants/guide/pa-files/PA-06-042.html). -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | August 18, 2026 23d left | — | Nonprofits |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | $499k | Nonprofits |
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |